erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the. would identify hospitals that are best positioned to treat strokes and establish protocols for emergency responders handling stroke patients.. august 2013  (15).